The Discounted Cash Flow (DCF) valuation of SkinBioTherapeutics PLC (SBTX.L) is (3,586.32) GBP. With the latest stock price at 16.25 GBP, the upside of SkinBioTherapeutics PLC based on DCF is -22169.7%.
Based on the latest price of 16.25 GBP and our DCF valuation, SkinBioTherapeutics PLC (SBTX.L) is a sell. selling SBTX.L stocks now will result in a potential gain of 22169.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.3% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (9,171.49) - (2,243.87) | (3,586.32) |
| Upside | -56539.9% - -13908.4% | -22169.7% |